UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059254
Receipt number R000067775
Scientific Title An exploratory observational study to examine the additional benefit of the CADe program aimed at supporting early gastric cancer detection by endoscopy
Date of disclosure of the study information 2025/12/31
Last modified on 2025/10/01 09:56:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory observational study to examine the additional benefit of the CADe program aimed at supporting early gastric cancer detection by endoscopy

Acronym

An exploratory observational study to examine the additional benefit of the CADe program aimed at supporting early gastric cancer detection by endoscopy

Scientific Title

An exploratory observational study to examine the additional benefit of the CADe program aimed at supporting early gastric cancer detection by endoscopy

Scientific Title:Acronym

An exploratory observational study to examine the additional benefit of the CADe program aimed at supporting early gastric cancer detection by endoscopy

Region

Japan


Condition

Condition

Gastric cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To exploratory study the additional benefit of CADe, which was developed to support the endoscopic detection of early gastric cancer, on the diagnostic ability of endoscopists using existing data (endoscopic video).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Number of gastric cancer patients detected only by second reading (when used in conjunction with the CADe program)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

99 years-old >=

Gender

Male and Female

Key inclusion criteria

Inclusion criteria for acquired endoscopic video information
Patients aged 20 years or older
Patients who have personally agreed to participate in the previous study
Patients who have not undergone total gastrectomy
Patients who have been found to have early gastric cancer through prior testing
Patients who have not been enrolled in other studies in the previous study
Patients who have been deemed by the previous study to be able to comply with instructions regarding the previous study and testing
Patients who have been deemed appropriate for participation in the previous study by the principal investigator (co-investigator)

Inclusion criteria for readers
- Physicians who perform upper gastrointestinal endoscopy as part of their daily work.
- Of the above criteria, an expert endoscopist is defined as someone who holds specialist certification from the Japan Gastroenterological Endoscopy Society and has more than 10 years of experience in gastrointestinal endoscopy, while a non-expert endoscopist is defined as someone who does not hold specialist certification from the Japan Gastroenterological Endoscopy Society and has less than 10 years of experience in gastrointestinal endoscopy.

Key exclusion criteria

Exclusion criteria for acquired endoscopic video information
Cases in which systematic and comprehensive lesion exploration of the entire gastric mucosa was not performed

Exclusion criteria for readers
A doctor who the principal investigator considers unsuitable to conduct this study

Target sample size

14


Research contact person

Name of lead principal investigator

1st name Kenshi
Middle name
Last name Yao

Organization

Fukuoka University Chikushi Hospital

Division name

Clinical Medicine Research Center

Zip code

818-8502

Address

1-1-1 Zokumyoin, Chikushino City, Fukuoka Prefecture

TEL

092-921-1011

Email

yao@fukuoka-u.ac.jp


Public contact

Name of contact person

1st name Masaki
Middle name
Last name Miyaoka

Organization

Fukuoka University Chikushi Hospital

Division name

Department of endoscopy

Zip code

818-8502

Address

1-1-1 Zokumyoin, Chikushino City, Fukuoka Prefecture

TEL

08052523770

Homepage URL


Email

miyaoka1@fukuoka-u.ac.jp


Sponsor or person

Institute

Fukuoka University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukuoka University - Ethics Review Board

Address

7-45-1 Nanakuma, Jonan Ward, Fukuoka City, Fukuoka Prefecture

Tel

092-801-1011

Email

fumed-ethics@fukuoka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 12 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 11 Month 20 Day

Date of IRB


Anticipated trial start date

2025 Year 12 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2025 Year 10 Month 01 Day

Last modified on

2025 Year 10 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067775